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ABSTRACT
Mycobacterium abscessus is the leading cause of lung infection in cystic fibrosis
patients and is often resistant to all antibiotics. There is an urgent need for alternative
therapies such as lytic bacteriophage (viruses that infect bacteria). Phage therapy has been
successful in the treatment of a drug-resistant M. abscessus infection in a teenaged cystic
fibrosis patient but there are challenges to broad use as most M. abscessus isolates are
highly resistant to lytic bacteriophage infection. Prophage, or integrated bacteriophage
genomes within the M. abscessus genome, likely defend against phage superinfection via
prophage-encoded viral defense systems. The Molloy lab has shown that the Mab cluster
R prophage McProf increases bacterial resistance to both bacteriophage superinfection and
antibiotics. To better understand the role of cluster R prophage in antibiotic resistance and
superinfection immunity, we identified and characterized 25 novel cluster R genomes in
sequenced clinical M. abscessus isolates. These strains encode a type VII secreted
polymorphic toxin (PT) system that we hypothesize play a role in drug resistance and
superinfection immunity. The PT cassettes include 1) a small ESXA-like protein, 2) a large
PT with a N-terminus WXG100 motif and a C-terminus toxin domain and 3) a cognate
immunity protein. There are two types of PT systems represented in the cluster R
genomes: a Tde1-like DNAse and a second PT with no recognizable toxin motif. Promoter
analysis of the MabR PT systems identified a poorly conserved putative SigA promoter.
To determine the role of PT in superinfection immunity and drug resistance, we attempted
to clone and express the PT system from the MabR prophage prophiFSAT01-1 but were
unable to isolate transformants in E. coli.
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INTRODUCTION

Mycobacterium abscessus is the leading cause of non-tuberculosis infection of soft
tissue and can cause serious lung infections in chronic lung disease patients, including
those

with

cystic

fibrosis

(CF)

(Jagielski

et

al.,

2016;

https://www.cdc.gov/hai/organisms/mycobacterium.html). Many M. abscessus isolates are
completely resistant to available antibiotics making it increasingly difficult to treat
infections (Degiacomi et al., 2019). To develop new treatments for pathogens like M.
abscessus, we need to better understand the mechanisms of pathogenicity and virulence.
There has been some success treating resistant M. abscessus infections with lytic phage
(Dedrick et al., 2020). However, strains differ vastly in their susceptibility to lytic phage
infection making it difficult to identify phages for phage therapy (Dedrick et al., 2021 (2)).
Resistance of these clinical isolates may be associated with colony morphology, smooth or
rough, and the presence of prophage within the bacterial genome that encode defense
systems against lytic phage infection (Dedrick et al., 2021 (2)). To improve treatment of
drug resistant M. abscessus infections, it will be important to investigate the role of
prophage in bacterial fitness including drug resistance and superinfection immunity.
Bacteriophage (phage) are viruses that infect bacteria while prophage are phage
genomes that are integrated into bacterial genomes. The bacterium that harbors the
prophage, is called a lysogen (Hatfull, 2011). Prophage maintain integration and lysogeny
by the expression of the prophage-encoded immunity repressor protein (Shimatake et al.,
1981). This repressor binds to specific DNA sequences in the phage genome to prevent
transcription of phage lytic genes during lysogeny (Brussow et al., 2004). This repressor
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can also bind to invading genomes of like phages to confer superinfection immunity to its
bacterial host (Brussow et al., 2004). Prophage can also express additional genes that
contribute to virulence and pathogenicity of the bacterial host. Escherichia coli O157:H7
causes illness through the expression of the Shiga-like toxin that is encoded by a prophage
genome (Fang et al., 2017). Some prophage that are suspected to play a role in virulence
do not always encode an obvious virulence factor, such as a toxin. For example, the genome
of M. tuberculosis strain H37Rv contains two prophage sequences that may contribute to
virulence in an unknown manner while the nonvirulent vaccine strain M. bovis BCG does
not carry any prophage sequences (Fan et al., 2016). It is hypothesized that these prophage
impact the pathogenicity of the mycobacterial host but the mechanism by which this occurs
is still unknown (Fan et al., 2016). It is possible that prophage can alter bacterial fitness
and virulence by influencing expression of bacterial virulence genes; however, there have
been few reports describing the role of prophage in mycobacterial fitness and gene
expression (Zhao et al., 2016).
The Molloy lab recently demonstrated that the presence of prophage contributes to
antibiotic resistance in mycobacteria. The prophage McProf, a naturally occurring
prophage in M. chelonae, increases antibiotic resistance in M. chelonae in response to
stress such as exposure to sub-lethal concentrations of drugs or phage superinfection
(Molloy, unpublished). This led the Molloy Lab to investigate the role of McProf genes in
antibiotic resistance. The strongest McProf gene candidate is a cassette that encodes a
secreted ESXA-like protein (a known secreted virulence factor in M. tuberculosis), a
polymorphic toxin and its cognate immunity protein (hereon called polymorphic toxin (PT)
system). McProf-like prophages are also found in M. abscessus strains. Given the
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significant impact of prophage McProf on mycobacteria fitness, it is important to
investigate the prevalence of this prophage in M. abscessus clinical isolates. Recently,
Dedrick et al. (2021) described 67 prophages from 82 M. abscessus clinical isolates and
nearly all these prophages carried a similar PT system with varying toxin/immunity protein
pairs. RNAseq analysis of these strains indicate that these PT systems are expressed with
the immunity protein being the most highly expressed of the three genes in the PT system
(Dedrick et al., 2021).
In this study, prophage related to McProf were identified in the genomes of M.
abscessus clinical isolates. These prophages were sorted into novel cluster MabR and the
genomes were annotated. Two distinct PT systems were characterized within the MabR
cluster. To determine the role of the novel PT system found in prophage prophiFSAT01-1,
the genome region encoding the promoter and three genes of the PT system were cloned
into an expression plasmid pFLAG_attP.
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LITERATURE REVIEW

Pathogenic Bacteria
Actinobacteria is one of the largest bacterial phyla and contains many pathogenic
bacteria. Actinobacteria are gram positive and contain a high percentage of guanine and
cysteine nucleotides over adenine and thymine (Barka et al., 2015). Bacteria of this phylum
are most often found in soil, water, and man-made water distribution systems (Percival,
2014). Mycobacterium is one of the most important genera that belongs to this phylum as
it contains many pathogens (Percival, 2014). Mycobacteria include obligate intracellular
pathogens, such as M. tuberculosis, which is the leading cause of death worldwide by an
infectious agent (WHO, 2020). Opportunistic non-tuberculosis mycobacterial pathogens
are also a serious threat to public health and, include M. chelonae, which causes soft-tissue
infections, and M. abscessus, which causes serious pulmonary diseases in patients with
chronic lung disease or cystic fibrosis (CF) patients. (Jagielski et al., 2016;
https://www.cdc.gov/hai/organisms/mycobacterium.html). Infections caused by M.
abscessus are of great concern due to its extensive resistance to antibiotics (Degiacomi et
al., 2019).
Because many isolates are completely resistant to all available antibiotics,
treatment of M. abscessus infections is challenging and often unsuccessful (Degiacomi et
al., 2019). Extensive drug resistance of mycobacteria creates a demand for alternative
treatments for mycobacterial infections. Using a cocktail of lytic bacteriophage, viruses
that infect bacteria, the Hatfull laboratory successfully treated a teenage CF patient on
palliative care due to a drug resistant M. abscessus infection (Dedrick et al., 2019). This is
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an exciting alternative treatment approach to drug resistant bacteria; however, it is
challenging to identify bacteriophage that can effectively infect and lyse each M. abscessus
isolate (Dedrick et al., 2019). This is likely due to strain morphotype and prophage(s), or
integrated phage genomes, that exist within the M. abscessus genome which are known to
defend against superinfection by a second phage (Dedrick et al., 2017). A recent study by
Dedrick et al. (2021 (b)) identified the role of strain morphotype on phage susceptibility.
M. abscessus strains with a smooth morphotype are less susceptible to superinfection
compared to strains with a rough morphotype (Dedrick et al., 2021 (b)).
Until 1992, M. chelonae and M. abscessus were classified as the same species due
to high genome sequence similarities. M. chelonae is an ideal model to study prophage
interactions and intrinsic antibiotic resistance pathways because, like M. abscessus and all
mycobacteria, it carries a conserved regulon of genes, called the WhiB7 regulon, that
contributes to intrinsic resistance in mycobacteria (Morris et al., 2005). M. chelonae can
cause disseminating infections of the skin through contaminated water or surgical site
infections (Uslu et al., 2019) but is overall safer to work with than other pathogenic
mycobacteria.

Although

M.

chelonae

infections

are

generally

found

in

immunocompromised individuals, immunocompetent individuals can develop an infection
(Ulsu et al., 2019). The overall prevalence of M. chelonae and M. abscessus infections
increases yearly, indicating a need for better treatment options (Lee et al., 2015).
Antibiotic Resistance
Mycobacterial infections are becoming increasingly harder to treat due to increased
antibiotic resistance (Jones et al., 2019). M. abscessus has high levels of innate resistance
to antimicrobial agents due to the large numbers of intrinsic resistance genes (Lee et al.,
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2015, Guo et al., 2020). There are only two different antibiotic regimens available to treat
M. abscessus infections and treatment is only successful in 45.6% of all cases (Chen et al.,
2019). Understanding the mechanism of how pathogenic mycobacteria are becoming
increasingly drug resistant is essential for developing new therapeutics.
Mycobacteria may be resistant due to acquired or intrinsic resistance mechanisms.
In acquired resistance, the mycobacteria have acquired a mutation that alters drug
resistance. For example, aminoglycosides are a type of antibiotic that binds to the 16s
rRNA of the 30S ribosomal subunit, and mutations in the 16s rRNA can inhibit binding of
aminoglycosides to the 30S ribosome resulting in resistance (Zaunbrecher et al., 2009).
Mycobacteria also have many intrinsic properties that make them difficult to treat and are
known for their selectively permeable cell wall which limits diffusion of small antibiotic
molecules across the cell wall (Nyugen, L., Thompson, C. 2006). Mycobacteria also
encode for genes that contribute to intrinsic antibiotic resistance and the expression of these
genes is upregulated in the presence of sub-inhibitory concentrations of antibiotics
(Nyugen, L., Thompson, C. 2006). Genes that confer antibiotic resistance include efflux
pumps, facilitator proteins, antibiotic degrading enzymes, and target modifying enzymes
(Nyugen, L., Thompson, C. 2006). Many of these genes belong to the WhiB7 regulon,
genes that are positively regulated by the transcription factor WhiB7.
WhiB7 is an autoregulated transcriptional activator of resistance genes that is
conserved across Actinobacteria (Hess, 2017; Morris et al., 2005). Gene expression is
dependent on a promoter that is 350-450 bp upstream of whiB7 in mycobacteria (Burian,
2018). There is an open reading frame (uORF) between the promoter and upstream of the
gene that does not encode a functional protein (Burian, 2018). The function of the uORF
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is to regulate transcript elongation across a transcriptional terminator sequence that is
located between the uORF and the whiB7 ORF (Burian, 2018). whiB7 transcription
increases with sub-inhibitory concentrations of antibiotics including tetracycline,
fluoroquinolones, macrolides, and aminoglycosides (Nyugen, L., Thompson, C. 2006).
Genes within the WhiB7 regulon include erm, eis, and the tetV efflux pump (Burian, 2018;
Hess et al., 2017).
The WhiB7 regulon contains genes that lead to resistance to aminoglycosides,
macrolides, and tetracycline (Burian et al., 2012; Burian, 2018; Hess et al., 2017). erm is
induced by macrolides and prohibits the macrolides from binding to site on the 23S rRNA
which prevents translation (Nyugen, 2006; Hess, 2017). eis acetylates aminoglycosides
which prevents the drug from binding to the 30S rRNA subunit and inhibits translation
(Burian et al., 2012). M. abscessus contains two eis genes and the second gene is
responsible for aminoglycoside resistance (Burian et al., 2012). tap and tetV use proton
motive force which works as an efflux pump to export aminoglycosides and tetracycline
from the cytoplasm (Burian et al., 2012 (b)). Mechanisms of regulation of antibiotic
resistance genes are well studied. While it is known that prophage alter antibiotic resistance
in some bacteria, their role in regulation of antibiotic resistance genes is not well studied
(Burian et al., 2012, Burian et al., 2012 (b), Burian, 2018, Hess et al, 2017, Wang et al.,
2010).
Bacteriophage and Prophage
Bacteriophage (phage) are viruses that infect bacteria and are the most abundant
biological entity. It is estimated that there are 1031 bacteriophages in the world (Hendrix,
2003). Bacteriophages are grouped together into clusters based on genome sequence
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identity and similar gene content (Pope et al., 2017). Mycobacteriophages are phages that
are able to infect bacteria from the genus Mycobacterium (Hatfull, 2014; Jacobs-Sera et a.,
2012; Pope et al., 2011). To date, 2,001 Mycobacteriophages have been sequenced and
belong to 29 clusters with clusters A, G, K, M, N, and O being well characterized (Russell
D., Hatfull, G. 2017).
Bacteriophage can carry out two different growth cycles, lytic or lysogenic
(Sampson et al., 2009). In the lytic pathway, phage genomes are replicated and packaged
into progeny phage and leave the host cell by lysis (Hatfull, 2011). In the lysogenic
pathway, the phage genome will fully integrate into the host genome (Hatfull, 2011). The
integrated phage genome is called a prophage and will replicate each time the host
replicates (Hatfull, 2011).
Understanding the lysogenic lifestyle allows us to understand the genome structure
of prophage. The left arm of a prophage typically encodes the early lytic and replication
genes, and the right arm encodes late lytic genes or genes involved in particle structure and
assembly (Dedrick et al., 2021). Following the structural genes and the lysis cassette on
the right arm, there is a region of accessory genes that typically are expressed from the
prophage during lysogeny and could impact bacterial fitness (Dedrick et al., 2021; Dedrick
et al., 2017). The genome ends are characterized by attachment sites, attL and attR which
are often adjacent to the integrase and immunity cassette. The prophage integrase allows
the prophage to establish and maintain lysogeny (Sampson et al., 2009). To maintain
lysogeny, the phage integrase recombines the phage genome into that of the host via phage
and bacterial attachment sites (attP and attB, respectively) (Hatfull et al., 2011). The phage
immunity repressor is one of the few genes expressed from the prophage during lysogeny
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and functions to repress expression of genes involved in the lytic cycle(Hatfull, et al.,
2011). During lysogeny, the bacterial cell containing the phage genome is termed a lysogen
and the integrated phage genome is termed a prophage (Hatfull et al., 2011; Petrova,
2015). During lysogeny, the bacterial cell containing the phage genome is termed a lysogen
and the integrated phage genome is termed a prophage (Hatfull et al., 2011)
Phage integrases use a site-specific mechanism to mediate integration (Groth et al.,
2004). A tyrosine or serine integrase is used which attacks the DNA sugar-phosphate
backbone at the site of recombination called the phage attachment site (attP) and the
bacterial attachment site (attB) (Groth et al., 2004). Most phage use a tyrosine integrase
that recognize core attachment sites 30-40 bp in length with an inverted recognition
sequence region (Groth et al., 2004). Recombination occurs when a nucleophilic tyrosine
nicks one strand of each att site which forms a Holliday junction and the Holliday junction
is resolved and results in attL (left) and attR (right) sites which are hybrid sequences of the
attP and attB sites (Holliday, 1964, Grindley et al., 2006, Groth et al., 2004). This leaves
the prophage sequence flanked by the attL and attR sites.
Typically, the most highly expressed gene during lysogeny is the immunity
repressor. The most well-studied repressor system is that of the temperate E. coli phage,
Lambda (ƛ) (Gao et al., 2013). The ƛ immunity cassette contains genes that encode
transcriptional regulators CI, CII, and Cro. CI and CII expression promotes lysogenic
growth and the control of the repressor’s operator Cro expression promotes lytic growth
(Atsumi, 2006). CI and Cro are divergently transcribed and there are three operator
sequences that overlap the promoters for these genes (Atsumi, 2006). From right to left the
operator sites are termed OR3, OR2, and OR1. The CI protein acts as a repressor for lytic
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genes by binding to OR1 and OR2 upstream of the promoter PR which prohibits the
polymerase from binding the rightward promoter and transcribing lytic genes including
Cro (Atsumi, 2006). Cro binds to OR3and OR2 upstream of the leftward promoter PRM
which prevents the transcription of CI so transcription of PR occurs and expression of lytic
genes (Atsumi, 2006).
The lytic/lysogenic decision is dependent on levels of CII transcriptional activator
that promotes transcription of integrase and of CI from the repressor establishment
promoter (Rokney et al., 2008). When the nutrient status of the cell is high, HflA protease
complex levels are high, and CII is degraded by the HflA protease complex. This allows
accumulation of Cro in the cells, transcription from PR, and the cells will undergo the lytic
cycle. When nutrient levels in the cell are low, HflA protease complexes are low, and CII
is not degraded by the HflA protease complex, allowing establishment of CI in the cells.
This allows continued transcription of PRM, and the phage undergoes the lysogenic growth
cycle (Rokney et al., 2008). Phage repressors, such as CI, can also bind to the genome of
similar superinfecting phage and prohibit lytic gene expression, thus conferring
superinfection immunity (Sampson et al., 2009). Although the Lambda model has provided
the most understanding about this system, CI/Cro systems have been found in many
prophages.
Prophage DNA can make up to 20% of the host’s genome content and frequently
are associated with bacterial pathogenicity and have been described in human pathogens
like Vibrio cholerae and Staphylococcus aureus (Fan et al., 2014, Zhao et al., 2016).
Prophage can be beneficial for the host by inducing specific virulence factors and
introducing new fitness factors (Fan et al., 2014, Zhao et al., 2016). Clinical isolates of M.
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tuberculosis have at least one copy of phiRv1 or phiRv2 which are upregulated during
oxygen-depletion and nutrient starvation (Bibb et al., 2002 and Fan et al., 2015). The
avirulent strain M. bovis is used for vaccination and contains no prophages (Bibb et al.,
2002). Experiments with E. coli have shown that removing all prophage leads to a reduced
drug resistance which implies that prophage impacts their hosts’ virulence and ability to
adapt to stress (Wang et al., 2016).
Prophage in mycobacterial diseases are not well studied even though almost all
pathogenic mycobacteria genomes carrying prophage (Fan et al., 2015). One paper
investigated non-mycobacterial genes in M. abscessus and identified three prophage-like
elements. The prophage proteins are underrepresented except when they are associated
with mycobacterial virulence which are overrepresented (Ripoll et al., 2009). PE and PPE
proteins were found in these prophages which are associated with ESX gene clusters (ATP
dependent Type VII secretion systems in mycobacteria) (Ripoll et al., 2009).
ESX systems have been studied in mycobacterial genomes but not in association
with prophages. These systems are type VII secretion systems and are linked to studies of
host-pathogen interactions in mycobacteria (Solomonson et al., 2015, Simeone et al.,
2015). ESX systems contain multi-protein complexes that include proteins with multiple
transmembrane domains, membrane-anchored proteins, secretion associated proteins,
substrates, and PE/PPE proteins (Simeone et al, 2015). The mechanism of secretion of ESX
substrates is not well understood but proteins containing a WXG100 domain are secreted
as homo or heterodimers and need a secretion signal (Solomonson et al. 2015). Secretion
of this system occurs using a YxxxD motif (Solomonson et al., 2015). ESX systems have
different functions, ESX-1 is found in M. tuberculosis and M. marinum and contribute to
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virulence by facilitating mycobacterial escape from the macrophage phagosome
(Solomonson et al., 2015, Simeone et al., 2015). When this ESX-1 system was added to
the avirulent M. bovis strain, virulence increased which suggests that ESX proteins are
linked to pathogen virulence (Simeone et al, 2015). The mechanism of ESX secretion and
the specific functions of secretion substrates are not well understood.
Many bacteria carry polymorphic toxin (PT) systems which are used to distinguish
between self and non-self for the purpose of survival (Garcia 2018). These systems include
a toxin that has specific enzymatic activity to kill or inhibit growth of neighboring bacteria
and an immunity protein that protects the producer bacteria self or kin recipients from toxin
activity (Mae et al., 2014). PT systems can be quite diverse in their specific activity but
overall, these systems have similar domain arrangement as the N-terminus encodes a
domain necessary for the toxin to interact with the secretion apparatus and the C-terminus
encodes the toxin (Ruhe et al., 2020). The PT systems of mycobacteria consist of coiledcoil domains with conserved Trp-Xaa-Gly (WXG) motifs at the N-terminus and immunity
proteins are most often located downstream to prevent self-intoxication (Ruhe et al., 2020).
While PT systems are well studied in bacteria, the prevalence of these systems in
bacteriophage is unknown (Ruhe et al., 2020). A recent study isolated and characterized
prophages from clinical M. abscessus isolates, many of the prophages described encoded
a PT system with diverse toxin and immunity protein functions (Dedrick et al. 2021).
M. chelonae prophage, McProf
McProf is a 67,657-bp prophage found in wild type M. chelonae (coordinates
1,521,426-1,589,648). McProf encodes 98 putative genes including structural genes,
replication genes, immunity genes, and genes that are expressed during lysogeny. The
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presence of the McProf prophage alters whiB7 expression and antibiotic resistance in
response to stress such as exposure to sub-lethal concentrations of antibiotics and
superinfection by a second phage (Molloy, unpublished). Genes expressed from the
McProf genome during lysogeny are hypothesized to play a role in altering whiB7
expression (Molloy, unpublished). Three strong gene candidates are the genes that make
up a polymorphic toxin system located adjacent to the right attachment site. Gp98 encodes
a WXG100 family protein, gp97 encodes the polymorphic toxin with a N-terminus
WXG100 domain and a C-terminus Tde1-like DNAse toxin, and gp96 encodes a Tdi-like
immunity protein (Molloy, unpublished). Sequences with high identity to the McProf
prophage genome were detected in the genomes of clinical M. abscessus isolates. Due to
the presence of McProf-like prophage genomes and polymorphic toxin systems in clinical
M. abscessus isolates and the role of McProf in altered drug resistance, characterizing this
novel group of prophages and their genome content could be important for understanding
intrinsic resistance and developing new treatments for multi-drug resistant M. abscessus.
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Figure 1. Genome map of prophage McProf. A. Genome map of McProf drawn to
scale with the ruler indicating coordinates of the genome in kilobasepairs (Kbp).
Genes transcribed in the forward direction are shown above the ruler while genes
transcribed in the reverse direction are shown below the ruler. Genes are color coded
based on similarity between other genes found in the Phamerator database. B. The
lysogenic gene expression profile of McProf while infecting M. chelonae. RNAseq
reads map to the forward (blue) and reverse (red) strands. C. Domains of the
polymorphic toxin system in McProf located in genes 96-98 (Molloy, unpublished).
14

MATERIALS AND METHODS

Prophage identification and sequence extraction
A BLAST analysis of the McProf prophage genome was performed in the PATRIC
database at phagesdb.org (Wattam et al., 2014 and Russell et al., 2017). The genomes of
mycobacterial strains containing McProf-like prophage sequences were entered into a webbased bioinformatic tool, PHASTER (Arndt et al., 2016), to determine the coordinates of
the prophage. The bacterial strain was uploaded into the bioinformatic tool Benchling and
the prophage sequence was extracted from the bacterial strain. Using NCBI BLASTN
(Altschul et al., 1990), attachment sites for the prophage were located by finding repeat
sequences that occur adjacent to the integrase gene. Prophage genomes were autoannotated using GeneMark (Lukashin et al., 1998) and Glimmer (Delcher et al., 1999)
embedded within DNA Master and PECAAN (http://cobamide2.bio.pitt.edu and
http://pecaan.kbrinsgd.org). Gene functions were predicted using HHpred (Zimmermann
et al., 2018) and NCBI BLASTP. The genomes of these prophages were scanned to find
genes that were not predicted by the bioinformatic tools. Genome maps and alignments
were performed in Phamerator (Cresawn et al., 2011).
Construction of prophiFSAT01-1 polymorphic toxin system expression plasmid
Three gBlock fragments containing the polymorphic toxin cassette of
prophiFSAT01-1 were ordered and synthesized by Integrated DNA Technologies (IDT,
San Diego, CA). These gBlock fragments were created based on complexity of the
sequences. The first gBlock fragment was 850bp long with a complexity score of 8.8, the
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second gBlock fragment was 1000bp with a complexity score of 6.4, the last gBlock
fragment was 1622bp with a complexity score of 5.6.
The plasmid, pFLAG_attP (Arnold et al., 2018), was digested with restriction
endonuclease SapI, according to the manufacturer’s instructions (New England BioLabs
(NEB), Ipswich, MA). This linearizes the plasmid for insertion of the G-Block fragments
and removes a suicide gene, called ccdB (Arnold et al., 2018). The 4006-bp fragment was
captured via a Lonza FlashGel Recovery Cassette according to the manufacturer’s
instructions (Lonza, Basel, Switzerland).

Figure 2. pFLAG_attP plasmid. The pFLAG_attP plasmid was digested using
restriction endonuclease SapI, cleaving 1661 bp from the plasmid and linearizing
the plasmid (Arnold et al., 2018).
16

Gibson Assembly cloning reactions containing the SapI-digested pFLAG_attP plasmid
and the polymorphic toxin system gBlocks were performed in 2:1 reaction ratios of
inserts to plasmid according to the manufacturer’s recommendations (NEB). Cloning
products were transformed into competent E. coli cells (NEB) and plated onto Luria agar
plates containing 50 μg mL-1 of apramycin to select for cells carrying the plasmid
construct. Plates were incubated at 37°C overnight. Colonies were grown overnight at
37°C in 5 mL of Luria broth (Miller) containing 50 μg mL-1 of apramycin. Plasmid DNA
was isolated via the Monarch® Plasmid Miniprep Kit (NEB) according to the
manufacturer’s instructions.
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Figure 3. Gibson Cloning of the polymorphic toxin system into SapI-digested pFLAG_attP
vector, adapted from Gibson et al. (2009). gBlocks Gene Fragments of the polymorphic toxin
system from prophiFSAT01-1 were ordered from IDT. These fragments were inserted into the
plasmid vector via Gibson Assembling Cloning to create pFLAG_FSAT_PT.

Agarose gel electrophoresis
PCR products were run on a 2% SeaKem® LE Agarose gel in 1X TAE buffer (40
mM Tris-acetate, 20 mM acetic acid, 2 mM ethylenediaminetetraacetic acid). Gels were
stained with ethidium bromide and visualized using the Azure Biosystems C200 Imaging
system.
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RESULTS

Identification of M. abscessus prophages
Using the McProf genome sequence as a probe, we identified 25 bacterial strains
carrying genome regions with high sequence identity to that of McProf. Using the tool
PHASTER, we identified coordinates of the McProf-like genomes and other cohabitating
prophage. These cohabitating prophages were described elsewhere. The prophage
sequences were extracted from the bacterial strains and annotated using tools in PECAAN.
Only eight of the McProf-like prophage sequences were unique (Table 1). The gene content
of these prophage was compared to that of the collection of prophages described by
Dedrick et al. (2021). The McProf-like genomes shared 0-10% genome content with the
Dedrick et al. (2021) prophages with the highest shared gene content with MabF prophages.
Prophage are entered into a cluster based on shared gene content, requiring >35% gene
content similarity (Pope et al., 2017; Dedrick et al., 2021). This warranted creating a new
M. abscessus prophage cluster, MabR. In total, eight new prophages were added to MabR
cluster

with

prophiFSMS01-1,

McProf:

prophiFSAT01-1,

prophiFSOD01-1,

prophiFSIG01-1,

prophiFSQJ01-1,

prophiFVMH01-1 (Figure 4).
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prophiFSIL01-1,

prophiFVLQ01-1,

and

Table 1. Cluster MabR genomes. Prophage name and bacterial isolate are shown along
with bacterial genome coordinates, prophage genome length, and number of prophage
encoded genes.

M. abscessus Isolate and
Bacterial Genomic
Prophage
Cluster Coordinates

Number of
Prophage Genome Prophage
Length (bp)
Encoded Genes

FSAT01
prophiFSAT01-1

MabR 2,104,368-2,172,096

67,728

99

MabR 162,999-228,799

65,800

97

MabR 17,536-85,245

67,709

96

MabR 102,082-178,718

76,636

119

MabR 360,992-427,679

66,687

99

MabR 162,543-229,039

66,496

93

66,496

96

67,742

113

FSIG01
prophiFSIG01-1

FSOD01
prophiFSOD01-1

FSQJ01
prophiFSQJ01-1

FVLQ01
prophiFVLQ01-1

FVMH01
prophiFVMH01-1

FSIL01
162,543-229,039

prophiFSIL01-1
FSMS01

MabR

prophiFSMS01-1

MabR 99,958-167,700
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Figure 4. Alignment of MabR genome maps. McProf is compared to seven novel MabR
prophage: prophiFSIL01-1, prophiFSMS01-1, prophiFSOD01-1, prophiFSQJ01-1,
prophiFVLQ01-1, prophiFSAT01-1, and prophiFVMH01-1 and prophiFSIG01-1 is not
shown. Shading between genomes indicates similarity in nucleotide sequence. Colored
shading between genome maps indicates nucleotide identity, purple through red representing
highest to lowest nucleotide identity.

Organization and gene content of the MabR prophages
The overall organization of the cluster MabR genomes is conserved and on average,
genomes are around 68 kpb in length. The genomes of the 9 members in cluster MabR have
high gene content similarity that does not warrant the need for sub-clustering although
there are regions of variation in early and late lytic gene regions and in the accessory gene
regions (Figure 4 and Figure 3). prophiFSOD01-1, prophiFSQJ01-1, and prophiFSMS011 are highly conserved with one another and encode minor tail proteins from different
Phams than the other cluster MabR genomes (Figure 4). The accessory genes of the MabR
genomes also showed variation in gene content, especially adjacent to the right attachment
site (Figure 4).
Here we describe the genome of prophiFSAT01-1 as a representative of the MabR
prophage genomes (Figure 5). ProphiFSAT01-1 is 67,728 bp in length (M. abscessus
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isolate FSAT01 contig 1 coordinates 2,104,368 - 2,172,096) and encodes 99 putative genes.
The prophage genome is flanked by 45-bp phage attachment sites, attL and attR (5’TGCGCCGTCAGGGGCTCGAACCCCGGACCCGCTGATTAAGAGTCA-3’).
Located adjacent to the left attachment site, attL, is a rightward transcribed tyrosine
integrase (gp1), a gene of unknown function (gp2), and a leftward transcribed immunity
repressor (gp3) (Figure 5A). Gp4 and gp5 both have helix-turn-helix DNA binding motifs
and encode Cro (control of repressor’s operator) and excise, respectively (Figure 5A).
Following these genes are the early lytic genes (gp6 - gp49) and the structural and assembly
genes (gp50 - gp80) (Figure 5A). Located between attR and the lysis genes (gp 74 - 80)
are genes typically expressed during lysogeny (Dedrick et al., 2017) (Figure 5A). Most of
these genes have unknown functions although we did identify an ADP-ribosyl
glycohydrolase (gp84), a helix-turn-helix DNA binding domain (gp87), and an AAAATPase (gp90) (Figure 5A). Leftward transcribed genes 95 - 98 encode proteins that may
be secreted by the mycobacterial type 7 secretion system (T7SS) (also known as Esx
secretion systems) (Figure 5B). Gp98 encodes a 109 amino acid gene with a WXG-100
family motif and high probability match to the EsxA (ESAT-6) protein of M. tuberculosis
(Figure 5B). Gp97 encodes a 750 amino acid polymorphic toxin that contains a WXG motif
in the N-terminus and a potential T7SS secretion signal (YxxxD/E) in the C-terminus
(Figure 5B). A toxin domain was not identifiable in the C-terminus of this gene, but the
structure of the cassette is consistent with polymorphic toxin systems reported by Dedrick
et al. (2021) (Figure 5B). Polymorphic toxins are generally paired with an immunity
protein, and gp96 is likely an immunity protein although typical immunity protein motifs
such as an -ank or -SUKH domain, were not detected in this protein (Figure 5B). Gp96 and
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95 have a type 4 secretion system motif, a secretion system found in H. pylori necessary
for translocating CagA (Chung et al., 2019). They also align to the N-terminus of a
lysis_col domain but the remainder of the protein sequence for gp96 and gp95 do not align
to any known proteins. Proteins containing a lysis_col domain are generally associated
with colicins as this domain is necessary for the release of colicins and partial cell lysis
(Uchimura et al., 1987). Colicin is a type of bacteriocin protein that is toxic to some strains

Figure 5. Genome Map of prophiFSAT01-1. A. Genome map of prophiFSAT01-1 drawn to
scale with the ruler indicating coordinates of the genome in kilobasepairs (Kbp). Genes
transcribed in the forward direction are shown above the ruler while genes transcribed in
the reverse direction are shown below the ruler. Genes are color coded based on similarity
between other genes found in the Phamerator database. Labels above genes indicate the
type of gene present. B. The PT system of prophiFSAT01-1, showing the domains present
of Escherichia coli (Cascales et al., 2007).
in each gene.
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Prophage encoded polymorphic toxin systems
MabR prophage encode two different types of polymorphic toxin systems (Figure
4). Both types include a WXG-100 protein in the first position of the cassette that is similar
to the EsxA (also known as ESAT-6) protein of M. tuberculosis (Simeone et al., 2015).
The polymorphic toxin systems differ in the polymorphic toxin and immunity protein
components. The first type of polymorphic toxin system has already been described in the
McProf prophage (Molloy, unpublished). This system encodes a WXG100 protein (gp98),
a polymorphic toxin with a Tde1-like DNAse toxin motif (gp97) and a Tdi-like immunity
protein (gp 96) (Figure 1C).). Gp96 contains a GAD domain and a DUF1851 domain that
is typical of Tdi immunity proteins (Figure 1C) (Ma et al., 2014; Zhang et al., 2012). This
system is found in other prophages belonging to cluster MabR, specifically prophiFSIG011, prophiFSIL01-1, and prophiFVMH01-1 (Figure 10). Prophage clusters MabC, MabD,
MabR, MabG, MabK, MabL, MabM, MabQ along with a prophage not belonging to a
cluster, called a singleton also contain the proteins belonging to the same pham (JacobsSera et al., 2012). The type 2 PT system of MabR prophages was described above in the
prophiFSAT01-1 genome. It is also found in the genomes of prophiFSMS01-1,
prophiFSOD01-1, prophiFSQJ01-1, and prophiFVLQ01-1 along with a prophage
belonging to MabQ called prophiGD79-1 (Figure 6).
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Figure 10. The PT system of
McProf and MabR Genomes. The
PT system of McProf is found
within other members of cluster
MabR, specifically prophiFSIL011,

prophiFVMH01-1,

and

prophiFSIG01-1 (not shown). The
genes belonging to this system are
pham 2492, 3205, and 1470.
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Figure 6. Type 2 polymorphic toxin
system of MabR prophage.
ProphiFSAT01-1, prophiFSMS01-1,
prophiFSOD01-1, prophiFSQJ01-1,
and prophiFVLQ01-1 contain a
different PT system than prophiMcProf.
This PT system contains a toxin
belonging to pham 1371, a group of
genes with highly related gene
sequences.
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There is some variation at the nucleotide level between the PT systems of
prophiFSAT01-1,

prophiFSMS01-1,

prophiFSOD01-1,

prophiFVLQ01-1

and

prophiFSQJ01-1 (Figure 6). The polymorphic toxin genes have high sequence identity at
the 3′ end of the gene, where the toxin is likely encoded. Despite this, the protein sequences
for these genes contain a WXG100 domain in the N-terminus. ProphiFSAT01-1 encodes a
PT system that is highly variable in nucleotide sequence compared to the other genomes.
However, the amino acid sequence of these genes is not highly conserved but the WXG
domain is maintained throughout these genes (Figure 12). The other interesting element
associated with the PT system is a gene adjacent to the PT system that is found in all the
MabR genomes with this PT system (Figure 7). In prophiFSAT01-1, this gene (gp95)
contains a lysis_col domain which is also present in prophiFSMS01-1, prophiFSOD01-1,
prophiFSQJ01-1, and prophiFVMH01-1. We do not know the function of this gene, but it
is interesting that is has some structural similarity to other bacterial toxins.
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Figure 7. Polymorphic toxin
cassettes of MabR genomes.
Adjacent to the polymorphic toxin
cassette of the MabR genomes is a
conserved gene belonging to pham
2779.
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Promoter Analysis
To better understand how these PT systems may be regulated, we investigated the
region upstream of the WXG100 protein (gp98 in McProf) to locate promoter sequences.
Promoters were predicted using the promoter hunter tool on phiSITE, however RNAseq
data showing expression of the McProf PT system in M. chelonae was used to support
phiSITE predicted promoters in the McProf genome. The RNAseq data indicates a start of
transcription close to coordinates 67,990 bp in the McProf genome. The promoter predicted
by phiSITE aligns with the predicted start of transcription from the RNAseq data and a +1
site was located from this data at 67,960 bp. The predicted promoter is not conserved across
all the genomes that carry this same system (Figure 8). However, an AT rich region
neighboring the predicted -10 box is present in all of the MabR genomes that encode this
PT system but there is no obvious -35 box upstream of this sequence (Figure 8).
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-35 box

-10 box

+1 site

Figure 8. Alignment of genome regions upstream of the Tde1-like PT systems with
predicted promoter sequences. A predicted promoter was identified upstream of the
McProf gp98 and the genome region was aligned with corresponding genome regions
of prophiFVMH01-1, prophiFSIl01-1, and prophiFSIG01-1, which encode the same
PT system. A SigA-like promoter, indicated by the red box, was detected in the
McProf genome just upstream of a predicted +1 start site, determined by RNAseq data.
The putative promoter sequence is not well conserved across the genomes. The yellow
highlighted sequence indicates a conserved AT rich region that could be an alternative
sigma promoter sequence.

Strain Construction of prophiFSAT01-1 Polymorphic Toxin System
The PT system encoded by the McProf genome is hypothesized to contribute to
altered gene expression and drug resistance in M. chelonae. To determine if the PT system
encoded by prophiFSAT01-1 could have a similar impact on bacterial gene expression, we
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aimed to clone and create recombinant strains expressing this second PT system in a strain
of M. chelonae that lacks prophage (Cushman et al., unpublished). The bacterial strain,
FSAT01, containing this prophage is not owned by the Molloy lab, and therefore we
designed a cloning experiment using three overlapping gBlocks™ Gene fragments by a
Gibson cloning reaction with linearized vector, pFLAG_attP to clone the three genes
(gp96-98) of prophiFSAT01-1 (Figure 3 and Figure 9) (Wang et al., 2018). The expression
vector, pFLAG_attP (Arnold et al., 2018), has a constitutive TET promoter, an apramycin
resistance gene for selection, and the L5 attP site for integration into the mycobacterial
genome (Figure 2). A single apramycin resistant E. coli colony was recovered and tested
for the presence of pFLAG_attP containing the insert by PCR and gel electrophoresis
analysis (Figure 11). A plasmid was not detected in this isolate indicating that either the
cloning reaction did not work, or the gene products were lethal in E. coli.
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Figure 9. pFLAG_attP plasmid map depicting prophiFSAT01-1 PT system
inserts. The overlapping gBlock fragments are indicated in red and are
labeled as Fragment 1, Fragment 2, and Fragment 3. The PT genes, gp96, 97,
and 98 of prophiFSAT01-1.
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Figure 11. Agarose gel
electrophoresis of PCR
diagnostic
The

products.

presence

and

absence of the PT
system

of

prophiFSAT01-1 was
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primers
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specific
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flanking
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are
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insert.
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2-4) and plasmid prep
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control,
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a
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PT

McProf

Figure 13. Model of pFLAG_FSAT_PT integration into M. chelonae. Integration
occurs by the L5 integrase acting on the attP and attB found on the phage and
bacterial genome, respectively. Once integrated, the attL and attR sites are present
in the lysogen.
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DISCUSSION

Mycobacteria are becoming increasingly drug resistant, creating a demand for
alternative treatments for mycobacterial infections (Lee et al., 2015). The role of prophage
in mycobacterial pathogenicity and antibiotic resistance is not well understood. Prophage
are believed to increase mycobacterial pathogenicity but the mechanism in which this
occurs is unknown (Fan et al., 2016). Upon lysogenic infection of a second phage called
BPs, M. chelonae WT, containing its naturally occurring prophage McProf, showed
differential expression of 8.5% of all genes (Cushman et al., unpublished). A
transcriptional activator for antibiotic resistance genes, whiB7, was one of the most highly
upregulated genes (Hurst-Hess et al., 2017). Studies conducted by the Molloy lab have
shown that there is significant increase in mycobacterial whiB7 expression and drug
resistance when McProf is present and exposed to stress such as superinfection by a second
phage or exposure to low levels of antibiotics (Cushman et al., unpublished). This indicates
that genes encoded by McProf could be essential in an enhanced stress response, resulting
in increased antibiotic resistance.
Genes expressed from McProf during lysogeny likely contribute to the altered drug
resistance of the bacterium and the gene expression profile of McProf during lysogeny is
known (Figure 1B). A type VII secretion system polymorphic toxin (PT) cassette is highly
expressed in the McProf genome and is a strong candidate for facilitating the altered drug
resistance and gene expression (Figure 1B). These PT systems contain a small WXG100
protein (gp98) which has a similar structure as the EsxA (ESAT-6) protein of the M.
tuberculosis Esx1 secretion system (Figure 1C) (Simeone et al., 2015). This gene likely

35

dimerizes using the WXG-100 motif with the toxin of this cassette and is secreted by a
bacterial Esx secretion system (Type VII secretion system) (Dedrick et al., 2021). Gp97
encodes a 732-amino acid polymorphic toxin with a N-terminal WXG motif and a Cterminal toxin_43 domain (Figure 1C). The WXG domain found on the N-terminal is
believed to contribute to secretion and the toxin_43 domain found on the C-terminal is
thought to be responsible for the toxic activity. Lastly, gp96 encodes the immunity protein
that contains a GAD and DUF1851 domain (Figure 1C). This polymorphic toxin system
was compared to known PT systems and matched the description of a Tde1-like toxin with
a hypothesized DNase activity and a Tdi-like immunity protein (Ma et al., 2014; Cushman
et al., unpublished). It is unknown if these systems are secreted into the media, into other
bacterial cells, or into eukaryotic cells. PT systems have been shown to play an antagonistic
role with non-kin cells that lack the immunity protein while allowing communication and
beneficial interactions between kin cells that encode the immunity protein (Ruhe et al.,
2020; Garcia 2018). In the bacterium Burkholderia, delivery of a DNAse toxin through
contact-dependent interactions to a non-kin cell is lethal. However, delivery of the toxin to
a kin cell which neutralizes the toxin with the immunity protein results in changes in gene
expression, including genes involved in biofilm formation (Garcia 2018). This benefits the
population of Burkholderia cells by allowing coordinated gene expression within a
population. A recent study conducted by the Hatfull lab described prophage-encoded PT
systems within the genomes of M. abscessus clinical isolates. These PT systems are
implicated in promoting cell growth of the infected host (Dedrick et al., 2021). The PT
systems found within these M. abscessus clinical isolates are structurally like the PT
systems described in the McProf genome. With the knowledge of the potential role of
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McProfs’ PT system in mind, the Molloy lab searched for prophages within M. abscessus
clinical isolates that contained a similar PT system.

Figure 10. The PT system of
McProf and MabR Genomes. The
PT system of McProf is found
within other members of cluster
MabR, specifically prophiFSIL011,

prophiFVMH01-1,

and

prophiFSIG01-1 (not shown). The
genes belonging to this system are
pham 2492, 3205, and 1470.
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To learn more about the role of PT systems and prophages like McProf, we
identified and characterized eight novel M. abscessus prophages that belong to the cluster
MabR (Table 1). The nine prophages of cluster MabR are highly conserved but there is
variation in three different regions of the genomes (Figure 4). Prophages prophiFSOD011, prophiFSQJ01-1, prophiFSMS01-1 have different minor tail proteins compared to the
other members of cluster MabR and these differences may impact the host range of these
prophages (Figure 4) (Jacobs-Sera et al., 2012). Variation was also seen in the accessory
genes, but the major difference exists in the type of PT system. Three of the MabR
prophages contain a similar PT system to McProf, carrying a Tde-like Dnase toxin (Figure
10). Prophage prophiFSAT01-1 and the other four members of MabR encode a PT system
for which the toxin motif has not been identified (Figure 6). An immunity protein was also
not identifiable, but gp96 and gp95 are candidates for the function of the immunity protein
due to convention gene organization of PT systems. A lysis_col domain was found in both
genes, a domain linked to colicin release which is a type of bacteriocin protein that is toxic
to some strains of E. coli. It is unclear if this gene encodes an additional toxin.
To determine if the PT system of prophiFSAT01-1 is similar to the PT system of
McProf by impacting gene expression and drug resistance, we attempted to clone this
system into M. chelonae (Figure 3). We conducted Gibson cloning reactions using
overlapping synthetic double stranded gene fragments that encode the PT system genes
from prophiFSAT01-1. This cloning technique has been successful in the past for the
Molloy lab but after two rounds of cloning, we were unable to successfully isolate E. coli
transformants carrying the plasmid construct (Figure 11). We do not know if this process
was not successful because the cloning reaction was not successful or if the gene products
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of this system are toxic in E. coli (Hatfull, personal communication). Based on the position
of gp96 of prophiFSAT01-1 downstream of the PT gene, we predicted that this gene is the
immunity protein. However, it lacked any obvious domains associated with immunity and
instead had structural similarities to the N-terminus of a colicin, a toxic protein to E. coli.
If gp96 has activity associated with a colicin, it could explain the failure to isolate
transformants with this plasmid construct. The location of these genes indicated to us that
they would encode a PT system, specifically that gp96 encodes an immunity protein but
this gene does not contain any motifs that would indicate an immunity protein. Instead, this
gene contains a lysis_col domain in the first thirty base pairs of the gene and if the gene is
related to a colicin and has toxic activity, this could explain why we were unable to
successfully clone this system into E. coli.
Research on McProf has shown the potential importance of the PT system on
antibiotic resistance but little is understood about how these genes are regulated. We used
RNA seq data and promoter hunting tools to search for conserved promoters across the
MabR genomes carrying the Tde1-like polymorphic toxin system. In the McProf genome,
a promoter was located upstream of the PT system that could be responsible for initiation
of transcription (Figure 8). This promoter is consistent with the consensus sequence of
promoter that are recognized by the mycobacterium’s housekeeping sigma, SigA (NewtonFoot et al., 2012). It is also adjacent to where we believe transcription begins based on
RNAseq data. However, the promoter is not conserved across the prophage genomes that
carry this PT system. Adjacent to the -10 box of this predicted promoter was a 6-bp AT
rich region that could be a promoter sequence, however an obvious -35 box was not
observed upstream of this sequence (Figure 8). Polymorphic toxin systems typically play

39

a large role in responding to stress, and therefore these genes may rely on an alternative
sigma protein that recognize promoter sequences that differ in structure than that of the
SigA promoter sequence. Other sigma factors like SigC, SigD, SigE, and SigH are involved
in virulence in M. tuberculosis (Kazmierczak et al., 2005).
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Figure 12. The toxin of the second PT system found in cluster MabR. A comparison
of the amino acid sequence of the toxin in the second PT system was completed. The
conserved WXG motif is outline in yellow.
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FUTURE WORK

Having access to the bacterial strain carrying prophiFSAT01-1 would have allowed
me to conduct more research on the effects of the PT system on bacterial pathogenicity.
Using the bacterial strain, I would have used multiple approaches to clone the genes of the
PT system as single or groups of genes. We could use alternative cloning approaches such
as FX cloning that have been successful in cloning the PT system of McProf. Cloning of
this system would allow me to determine the function of these genes and how they effect
antibiotic resistance. If I had access to the FSAT01 strain, I would have cured the strain of
prophiFSAT01-1,
meaning
would
have strain.
removed
thewould
prophage
bacterial strain..
removed
the prophage
fromIthe
bacterial
This
allowfrom
me the
to investigate
gene
expression of the bacterium with and without the presence of a prophage.

Figure 13. Model of pFLAG_FSAT_PT integration into M. chelonae. Integration
occurs by the L5 integrase acting on the attP and attB found on the phage and bacterial
genome, respectively. Once integrated, the attL and attR sites are present in the
lysogen.
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